A significant advance in cancer investigation is emerging with the use of VHH fragments to re-engage damaged p53. This vital malignant inhibitor protein is frequently inactivated in several types of cancer, resulting https://crossbookmark.com/story21810077/mini-antibodies-reactivate-tumor-suppressor-p53-a-new-hope-for-cancer-management